A Publicly Listed Pharmaceutical Company
?Challenge
This publicly listed pharmaceutical company produces over 500 million drug units annually and must comply with China's drug informatization traceability standards, US DSCSA, and other multi-country regulatory requirements. The company also faced severe drug diversion, difficulty monitoring returned drugs, and frequent consumer counterfeit drug complaints. Traditional manual record-keeping was inefficient with questionable data integrity, and retrieving data during regulatory surprise inspections was time-consuming.
!Solution
Deployed ZhiShuYun's electronic supervision code traceability system implementing multi-level serialization from individual unit to box to case to pallet. Full lifecycle data is automatically collected and retained, supporting online audits by drug regulatory authorities. The channel flow control system enables full-chain tracking of pharmaceuticals from manufacturers to wholesalers, hospitals, and pharmacies. Consumers can verify drug authenticity, view batch information, and check expiration dates with a single scan. The blockchain module records critical traceability data on-chain to prevent data tampering.
Results
After system launch, drug traceability compliance achieved a 100% pass rate in both provincial and national regulatory audits. Channel inspection efficiency improved 4x with labor costs reduced by 60%. Consumer counterfeit drug complaints dropped to zero within 3 months. The blockchain notarization technology received regulatory recognition and is promoted as an industry compliance benchmark.